Washington University in St. Louis Leads International Alzheimer’s Clinical Trial to Test Tau Drugs

An international clinical trial aimed at finding treatments for Alzheimer’s disease has expanded to include investigational drugs targeting a harmful form of the brain protein tau. Originally focused on amyloid-based therapies, the trial launched with funding from the National Institute on Aging (NIA) of the National Institutes of Health (NIH) in 2013. Source: HEC Media